Concert Pharmaceuticals, Inc. CNCE
8.37 +8.37
Day range unavailable
52-week range unavailable
CNCE revenue history
Revenue is income from the company’s ordinary business activities.
32,578,000 USD
FY 2021 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2021 | 2021-12-31 | 32,578,000 | 24,676,000 | 312.28% |
| FY 2020 | 2020-12-31 | 7,902,000 | 6,825,000 | 633.70% |
| FY 2019 | 2019-12-31 | 1,077,000 | -9,428,000 | -89.75% |
| FY 2018 | 2018-12-31 | 10,505,000 | -133,386,000 | -92.70% |
| FY 2017 | 2017-12-31 | 143,891,000 | 143,717,000 | 82595.98% |
| FY 2016 | 2016-12-31 | 174,000 | -66,555,000 | -99.74% |
| FY 2015 | 2015-12-31 | 66,729,000 | 58,153,000 | 678.09% |
| FY 2014 | 2014-12-31 | 8,576,000 | -16,832,000 | -66.25% |
| FY 2013 | 2013-12-31 | 25,408,000 | 12,559,000 | 97.74% |
| FY 2012 | 2012-12-31 | 12,849,000 | -6,618,000 | -34.00% |
| FY 2011 | 2011-12-31 | 19,467,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:03.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.